AUSTIN, Texas, Dec. 5 /PRNewswire/ -- CN Group and Texas Healthcare and Bioscience Institute, organizers of the 4th annual Southwest Bio Venture Conference & Symposium, today announced participating companies for the region’s premier life sciences event. Fifteen companies from across the Southwest have been selected to present at Southwest Bio Venture, to be held December 9 and 10, 2003 in the Hyatt Regency Imperial Ballroom in Houston, Texas.
Southwest Bio Venture will highlight some of the Southwest’s most prominent life sciences investment opportunities and will explore the latest industry trends and new business opportunities. The two day program includes keynotes and advisory panels of venture fund and business advisers.
“We are very excited about the investment opportunities being presented at this year’s conference,” said David Gerhardt, the managing director of CN Group. “Having growth-oriented companies of this caliber speaks volumes to the growing strength of the Southwest as one of most unique and attractive areas of life science investing in the nation.”
Presenting companies include (in order of presentation): -- Azopax (Boston / Austin) - Presentation by Steve Rowe -- PLx Pharma (Houston) - Presentation by Rom Zimmerman -- Lingual Care (Dallas) - Presentation by Lea Nesbit -- Organ Transport Systems (Dallas) - Presentation by Bob Kramer -- Amarillo Biosciences, Inc. (Amarillo) - Presentation by Joe Cummins -- Advocate MD (Austin) - Presentation by Mark Adams -- Opexa Pharmaceuticals (Houston) - Presentation by Michael Redman -- Kardia Therapeutics (Houston) - Presentation by William Altman -- Aronell Pharmaceuticals (Fort Worth) - Presentation by Nick Kerkhof -- C Sixty (Houston) - Presentation by Russ Lebovitz -- Spin Diagnostics (Houston) - Presentation by Shishir Shah -- VidaCare (San Antonio) - Presentation by Jim Thompsen -- Acclaim Biotechnology (Houston) - Presentation by John Chan -- Chrysilis Bio Technologies (Galveston) - Presentation by Dennis McWilliams -- MCRI (Austin) - Presentation by Bill Cooper About CN Group
CN Group helps build growth companies through three business efforts. CN Events produces the leading Venture Capital, Private Equity and Angel Investor gatherings in the Southwest. CN Management Services assists companies in building their management team and Board and Advisory Boards. Capital Network Securities, a NASD-approved investment bank, provides merger and acquisition advisory services, and capital-raising services for select growth companies. For more information please visit http://www.cngroupllc.com/ .
About Texas Healthcare and Bioscience Institute
Texas Healthcare and Bioscience Institute (THBI) is a public policy research organization whose members consist of biotechnology, medical device, and pharmaceutical companies; academic and private research institutions; chambers of commerce; and local and regional economic development foundations. The mission of THBI is to research, develop and advocate policies that promote life science innovation in Texas. For more information, visit http://www.thbi.com/ .
Media Contact: Patti D. Hill BlabberMouth Public Relations (512) 528 - 0201 patti@blabbermouthPR.com
CN Group; Texas Healthcare and Bioscience Institute
CONTACT: Patti D. Hill of BlabberMouth Public Relations,+1-512-528-0201, or patti@blabbermouthPR.com , for CN Group
